Article Versions Notes

Cheema PK, Syed I, Gwadry-Sridhar F, Rakibuz-Zaman M, Sachdeva R, Pencz A, Zhan L, Hueniken K, Patel D, Balaratnam K, et al. Programmed Cell Death-Ligand 1 Expression and Clinical Outcomes Among Patients with Resected, Early-Stage Non-Small Cell Lung Cancer: A Real-World Study. Current Oncology. 2024; 31(11):6735-6748. https://doi.org/10.3390/curroncol31110497

Cheema, Parneet K., Iqra Syed, Femida Gwadry-Sridhar, Muhammad Rakibuz-Zaman, Robin Sachdeva, Alec Pencz, Luna Zhan, Katrina Hueniken, Devalben Patel, Karmugi Balaratnam, and et al. 2024. "Programmed Cell Death-Ligand 1 Expression and Clinical Outcomes Among Patients with Resected, Early-Stage Non-Small Cell Lung Cancer: A Real-World Study" Current Oncology 31, no. 11: 6735-6748. https://doi.org/10.3390/curroncol31110497

Cheema, P. K., Syed, I., Gwadry-Sridhar, F., Rakibuz-Zaman, M., Sachdeva, R., Pencz, A., Zhan, L., Hueniken, K., Patel, D., Balaratnam, K., Khan, K., Grant, B., Sheffield, B. S., Locke, M. E. O., Moldaver, D., Shanahan, M. K., Liu, G., & Kuruvilla, M. S. (2024). Programmed Cell Death-Ligand 1 Expression and Clinical Outcomes Among Patients with Resected, Early-Stage Non-Small Cell Lung Cancer: A Real-World Study. Current Oncology, 31(11), 6735-6748. https://doi.org/10.3390/curroncol31110497